In Vitro Diagnostics and Theranostics: World Market Analysis 2010-2025

Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!

In Vitro Diagnostics and Theranostics: World Market Analysis
2010-2025
Published on June 2010

Report Summary

Our new report examines the commercial prospects for in vitro diagnostics (IVD) in the global healthcare market. Those technological
solutions are playing an important role in clinical practice and pharmaceutical R&D - increasing safety, speeding up clinical
development and facilitating regulatory acceptance. Molecular diagnostic technologies are leading healthcare towards the goal of
personalised medicine, to the benefit of healthcare stakeholders. Molecular diagnostic tests receive support from pharmaceutical
regulators, such as the FDA.

We believe that some of the greatest opportunities ever available for diagnostics companies are present, with important sales,
licensing and partnership developments to occur from 2010 onwards. Pharmaceutical companies also stand to gain, through the
benefits of molecular diagnostics. We predict increasing revenues in the years ahead. Do you want to know where the most-promising
opportunities will occur' How will companies adapt to the opportunities and challenges' In Vitro Diagnostics and Theranostics: World
Market Analysis 2010-2025 answers those and many other questions, providing the information that you require.

Our new report also covers theranostics, a fusion of drug therapy and diagnostics to optimise efficacy and safety, as well as
streamline drug development. Combining a drug with a diagnostic test is also known as companion diagnostics, integrated medicine,
pharmacodiagnostics and Dx/Rx partnering. This emerging field is generating strong interest from the healthcare industry and
regulatory bodies, with the associated market expanding as the importance of theranostics is recognised, especially in cancer
treatment.

Detailed analysis of the in vitro diagnostics industry and market

In Vitro Diagnostics and Theranostics: World Market Analysis 2010-2025 examines that sector through a comprehensive review of
information sources. We harness both primary and secondary research. This report provides unique sales forecasts, market share
analyses, discussions of emerging technologies and analyses of commercial drivers and restraints, including a SWOT analysis. There
are over 110 tables and figures included, as well as four interviews with experts. The result is a comprehensive market- and
industry-centred study, with detailed analyses and informed opinion to benefit your work.

Why you should buy In Vitro Diagnostics and Theranostics: World Market Analysis 2010-2025

This report gives you the following benefits in particular:
' You will receive a comprehensive analysis of the prospects for in-vitro diagnostics from 2010 to 2025, with quantitative and
qualitative analyses
' You will receive an overall revenue forecast for that market area from 2010 to 2025, as well as those for main subdivisions (by
technology and application), with comprehensive discussions and other supporting information
' You will discover predicted revenues, growth rates and other data for theranostic solutions from 2010 to 2025
' You will receive forecasts for IVD sales in leading national markets (US, Japan, Germany, France, UK, Italy, Spain, China and India)
from 2010 to 2025
' You will identify emerging technologies, assessing their potential
' You will discover activities of companies in the IVD sector - both established and emerging players - including partnerships
' You will discover the drivers, restraints, competition and opportunities influencing the in vitro diagnostics and theranostics sectors

In Vitro Diagnostics and Theranostics: World Market Analysis 2010-2025 (From Slideshare) Page 1/10


' You will investigate under-met needs in the IVD sector, with medical requirements and commercial opportunities discussed
' You will receive expert views from our survey, including full interview transcripts.

You can obtain this report today

This report is essential reading for everybody interested in the healthcare diagnostics and biotechnology sectors. With expanding
patient populations and under-met needs worldwide - especially for better-targeted and more-cost-effective medicines - the diagnostic
and pharma industries can benefit. Do you want to harness those technological and commercial opportunities' You can stay ahead by
ordering this report today.

Table of Content

Table of Contents
1. Executive Summary
1.1 The Scope of this Report
1.2 Chapter Outlines
1.3 Research and Analysis Methods

2. Introduction to In Vitro Diagnostics
2.1 What are In Vitro Diagnostic Tests'
2.2 Classifying IVD: EDMA Classification
2.2.1 Clinical Chemistry
2.2.2 Immunochemistry
2.2.3 Haematology
2.2.4 Microbiology
2.2.5 Genetic Testing
2.3 Classifying IVD: Disease Areas
2.4 Regulatory Issues
2.4.1 FDA Classifications
2.4.2 Regulation of IVD Tests
2.5 Types of IVD Tests
2.6 Personalised Medicine: Pharmacogenomics, Pharmacogenetics, Theranostics, and Proteomics
2.6.1 Pharmacogenomics
2.6.2 Proteomics
2.7 Sensitivity and Specificity

3. In Vitro Diagnostics Market: Global Outlook 2010-2025
3.1 The Global IVD Market in 2009
3.2 Global IVD Market: Forecast 2010-2025
3.3 Global IVD Market: Forecasts by EDMA Category 2010-2025
3.3.1 Clinical Chemistry: Forecast 2010-2025
3.3.2 Immunochemistry: Forecast 2010-2025
3.3.3 Haematology: Forecast 2010-2025



3.3.4 Microbiology (Culture): Forecast 2010-2025
3.3.5 Immunotechnology for Infectious Diseases: Forecast 2010-2025
3.3.6 Genetic Testing: Forecast 2010-2025
3.4 Point-of-Care Testing: Forecast 2010-2025
3.5 Laboratory Testing: Forecast 2010-2025

4. In Vitro Diagnostics: Leading National Markets
4.1 Leading IVD Markets in 2009
4.2 Forecasts by Country 2010-2025
4.3 US IVD Market: Forecast and Outlook 2010-2025
4.4 Japanese IVD Market: Forecast and Outlook 2010-2025
4.5 Leading European IVD Markets: Forecasts and Outlook 2010-2025
4.6 Chinese IVD Market: Forecast and Outlook 2010-2025
4.7 Indian IVD Market: Forecast and Outlook 2010-2025
4.8 How National Market Shares will Change During the Forecast Period
4.9 Global IVD Market by Region

5. Some Leading Companies in the IVD Sector
5.1 IVD Manufacturers
5.1.1 Roche
5.1.2 Siemens AG
5.1.3 Abbott Laboratories
5.1.4 Beckman Coulter
5.1.5 Becton Dickinson
5.2 Laboratory Services
5.2.1 Quest Diagnostics
5.2.2 Laboratory Corporation of America
5.3 Direct-to-Consumer Genomic Testing Companies

6. Important Therapy Areas for IVD Tests
6.1 Diabetes
6.2 Oncology
6.3 Infectious Disease
6.3.1 Hospital-Acquired Infections
6.3.2 HIV
6.3.3 Tuberculosis
6.3.3.1 Skin Tests
6.3.3.2 Smear Microscopy
6.3.3.3 Microbiological Culture
6.3.3.4 Nucleic Acid-Based Testing
6.3.3.5 Immunoassays
6.3.3.6 Phage Assay
6.3.4 Influenza
6.4 Reproductive Tests
6.5 Drugs of Abuse
6.5.1 Drugs Commonly Tested For
6.5.2 Types of Sample
6.6 Cardiovascular Disease



6.6.1 Cardiac Markers
6.6.2 Cholesterol Screening

7. Personalised Medicine and Theranostics
7.1 What is Personalised Medicine'
7.2 Maximising Benefits to Healthcare Stakeholders
7.3 Minimising Harm
7.4 Increasing Patient Compliance
7.5 Streamlining Clinical Trials
7.6 Reviving Failed or Withdrawn Drugs
7.7 Reducing the Costs of Healthcare
7.8 Shifting From Reaction to Prevention
7.9 What is Required for Personalised Medicine to Become Widespread'
7.9.1 The Cost of Genomic Sequencing Must Fall Further
7.9.2 Large-Scale Studies and Databases
7.9.3 A Healthcare IT Infrastructure that Integrates Clinical Data and Other Research
7.9.4 Medical Education
7.9.5 Guaranteed Reimbursements'
7.10 Theranostics Forecast

8. Commercial Drivers and Restraints in the IVD Sector 2010-2025
8.1 SWOT Analysis of the IVD Market Area
8.2 Factors Driving Growth of the IVD Market
8.3 Factors Restraining Growth of the IVD Market

9. Interviews with Industry Experts
9.1 Interview 1: Director of a Diagnostics Company
9.1.1 Most-Promising Therapeutic Areas for IVD
9.1.2 Unmet Medical Needs in IVD
9.1.3 Greatest Obstacles to Market Growth
9.1.4 Prospects for IVD Market Growth in Developing Countries
9.1.5 Prospects for Theranostics
9.2 Interview 2: CEO of a Diagnostics Company
9.3 Interview 3: Director of a Diagnostics Company
9.4 Interview 4: Business Development Director of a Diagnostics Company




10. Conclusions
10.1 In Vitro Diagnostics are Vital to Clinical Decision Making
10.2 Significant Growth of In Vitro Diagnostics Market from 2010 to 2025
10.3 The Top Five Manufacturers Command the Majority of the IVD Market
10.4 Expansion of the World Market Boosted by Rising Sales in the Developing Healthcare Markets
10.5 IVD Solutions are the Cornerstone of Personalised Medicine
10.6 Expansion into Developing National Markets and Lifestyle Diseases Will Drive Market

List of Tables

Table 2.1 Criticisms of the CLIA System
Table 3.1 Global IVD Market: Revenues by EDMA Category, 2009
Table 3.2 The Global IVD Market: Revenue Forecast, 2010-2025
Table 3.3 Global IVD Market: Revenue Forecast by Submarket, 2010-2015
Table 3.4 Clinical Chemistry IVD Applications, 2010
Table 3.5 Clinical Chemistry IVD Market: Revenue Forecast, 2010-2025
Table 3.6 Immunochemistry IVD Applications, 2010
Table 3.7 Immunochemistry IVD Market: Revenue Forecast, 2010-2025
Table 3.8 Haematology IVD Applications, 2010
Table 3.9 Haematology IVD Market: Revenue Forecast, 2010-2025
Table 3.10 Microbiological Culture Applications, 2010
Table 3.11 Microbiology Culture IVD Market: Revenue Forecast, 2010-2025
Table 3.12 Infectious Immunology Applications, 2010
Table 3.13 Infectious Immunology Market: Revenue Forecast, 2010-2025
Table 3.14 Genetic Testing Applications, 2010
Table 3.15 Genetic Testing Market: Revenue Forecast, 2010-2025
Table 3.16 POCT and Laboratory Testing Market Shares by Revenue, 2009
Table 3.17 The Point-of-Care IVD Market: Revenue Forecast, 2010-2025
Table 3.18 The Laboratory Testing Market: Revenue Forecast, 2010-2025
Table 3.19 The Laboratory Testing and POCT Markets: Revenue Forecasts, 2010-2025
Table 4.1 Leading IVD Markets by Revenue, 2009
Table 4.2 Nine Leading National IVD Markets: Revenue Forecasts, 2010-2025
Table 4.3 The US IVD Market: Revenue Forecast, 2010-2025
Table 4.4 The US IVD Market: Revenue Forecast, 2010-2025
Table 4.5 Healthcare Budgets and IVD Spending of Top Five European Countries, 2009
Table 4.6 The German IVD Market: Revenue Forecast, 2010-2025
Table 4.7 The French IVD Market: Revenue Forecast, 2010-2025
Table 4.8 The Italian IVD Market: Revenue Forecast, 2010-2025
Table 4.9 The Spanish IVD Market: Revenue Forecast, 2010-2025
Table 4.10 The UK IVD Market: Revenue Forecast, 2010-2025
Table 4.11 The Chinese IVD Market: Revenue Forecast, 2010-2025
Table 4.12 The Indian IVD Market: Revenue Forecast, 2010-2025
Table 4.13 Global IVD Market by Regional Revenue Shares, 2009
Table 5.1 Top Five IVD Manufacturers by Revenue, 2009
Table 5.2 Roche: Diagnostic Business Revenues, 2009



Table 5.3 Roche: Bestselling IVD Products, 2009
Table 5.4 Siemens: Revenues by Business Segment, 2009
Table 5.5 Abbott: Revenues by Business Segment, 2009
Table 5.6 Beckman Coulter: Revenues by Business Segment, 2009
Table 5.7 BD: Revenues by Business Segment, 2009
Table 5.8 Quest: Revenues by Business Segment, 2009
Table 5.9 LabCorp: Revenues by Business Segment, 2009
Table 5.10 Conditions Tested for by 23andMe, 2010
Table 6.1 Key Disease Areas: Revenues from IVDs, 2009
Table 6.2 Diabetes Market by Marker, 2009
Table 6.3 POCT by Application, 2009
Table 6.4 Cancer IVD Revenues, 2009
Table 6.5 Theranostics for Oncology, 2010
Table 6.6 Infectious Disease IVD Market by Technology, 2009
Table 6.7 Infectious Disease IVD Market: Revenues by Disease, 2009
Table 6.8 HIV IVD Market: Revenues by Application, 2009
Table 6.9 TB Diagnostics by Revenue, 2009
Table 6.10 Male and Female Fertility Markers, 2010
Table 6.11 Detection Windows for Various DoA Tests, 2010
Table 6.12 Cardiovascular IVD Market: Revenue by Application, 2009
Table 6.13 Common Cardiac Markers, 2010
Table 6.14 Cardiac Marker IVD Market: Revenues by Test Type, 2009
Table 7.1 Comparison of Traditional and Personalised Medicine, 2010
Table 7.2 Average Response Rates to Treatment for Various Diseases, 2010
Table 7.3 Drugs Metabolised by CYP450: 2C19 and 2D6, 2010
Table 7.4 The Falling Cost of Sequencing Complete Human Genome
Table 7.5 Diagnostics and Theranostics: Revenue Forecasts, 2010-2025
Table 7.6 Genetic IVDs: Theranostics and Other Tests Revenue Forecasts, 2010-2025
Table 8.1 SWOT Analysis of IVD Market, 2010-2025

List of Figures
Figure 3.1 Global IVD Market: Revenues by EDMA Category, 2009
Figure 3.2 The Global IVD Market: Revenue Forecast, 2010-2025
Figure 3.3 Global IVD Market: Revenue Forecast by Submarket, 2010-2015
Figure 3.4 Clinical Chemistry IVD Market: Revenue Forecast, 2010-2025
Figure 3.5 Immunochemistry IVD Market: Revenue Forecast, 2010-2025
Figure 3.6 Haematology IVD Market: Revenue Forecast, 2010-2025
Figure 3.7 Microbiology Culture IVD Market: Revenue Forecast, 2010-2025
Figure 3.8 Infectious Immunology Market: Revenue Forecast, 2010-2025
Figure 3.9 Genetic Testing Market: Revenue Forecast, 2010-2025
Figure 3.10 POCT and Laboratory Testing Market Shares, 2009
Figure 3.11 The Point-of-Care IVD Market: Revenue Forecast, 2010-2025
Figure 3.12 The Laboratory Testing Market: Revenue Forecast, 2010-2025
Figure 3.13 The Laboratory Testing and POCT Markets: Revenue Forecasts, 2010-2025
Figure 4.1 Leading National IVD Markets by Share of Worldwide Revenue, 2009
Figure 4.2 Leading National IVD Markets (Upper Tier): Revenue Forecasts, 2010-2025
Figure 4.3 Leading National IVD Markets (Lower Tier): Revenue Forecast, 2010-2025
Figure 4.4 The US IVD Market: Revenue Forecast, 2010-2025



Figure 4.5 The Japanese IVD Market: Revenue Forecast, 2010-2025
Figure 4.6 The German IVD Market: Revenue Forecast, 2010-2025
Figure 4.7 The French IVD Market: Revenue Forecast, 2010-2025
Figure 4.8 The Italian IVD Market: Revenue Forecast, 2010-2025
Figure 4.9 The Spanish IVD Market: Revenue Forecast, 2010-2025
Figure 4.10 The UK IVD Market: Revenue Forecast, 2010-2025
Figure 4.11 The Chinese IVD Market: Revenue Forecast, 2010-2025
Figure 4.12 The Indian IVD Market: Revenue Forecast, 2010-2025
Figure 4.13 Market Shares of Leading National Markets, 2010
Figure 4.17 Global IVD Market by Region, 2009
Figure 5.1 Market Shares of the Top Five IVD Manufacturers, 2009
Figure 5.2 Roche: Diagnostic Business by Revenue, 2009
Figure 5.3 Roche: Bestselling IVD Products, 2009
Figure 5.4 Siemens Healthcare: Revenues by Division, 2009
Figure 5.5 Siemens AG: Revenues by Business Segment, 2009
Figure 5.6 Abbott: Revenues by Business Segment, 2009
Figure 5.7 Beckman Coulter: Revenues by Business Segment, 2009
Figure 5.8 BD: Revenues by Business Segment, 2009
Figure 5.9 Quest: Revenues by Business Segment, 2009
Figure 5.10 LabCorp: Revenues by Business Segment, 2009
Figure 6.1 Key Disease Areas: Revenues from IVD Applications, 2009
Figure 6.2 Diabetes Market by Marker, 2009
Figure 6.3 POCT Market by Application, 2009
Figure 6.4 Cancer IVD Revenues, 2009
Figure 6.5 Infectious Disease IVD Market: Revenues by Technology, 2009
Figure 6.6 Infectious Disease IVD Market: Revenues by Disease, 2009
Figure 6.7 HIV IVD Market: Market Shares by Application, 2009
Figure 6.8 TB Diagnostics by Revenue, 2009
Figure 6.9 Cardiovascular IVD: Market Shares by Application, 2009
Figure 6.10 Cardiac Marker IVDs: Market Shares by Test Type, 2009
Figure 7.1 Average Response Rates to Treatment for Various Diseases, 2010
Figure 7.2 The Falling Cost of Sequencing the Whole Human Genome
Figure 7.3 Theranostic IVD Market: Revenue Forecast, 2010-2025
Figure 7.4 Global IVD Market: Theranostic and Diagnostic Market Shares, 2010-2025
Figure 7.5 Genetic IVD Applications: Revenue Forecasts for Theranostics and Other Tests, 2010-2025

Companies cites

23andMe
Abbott Laboratories
AmeriPath
Axis-Shield
Beckman Coulter
Becton, Dickinson & Company
BIOTEC Laboratories



bioTheranostics
Cellestis
Center for Disease Control and Prevention (CDC)
Clinical Data
Complete Genomics
Dade Behring
Dianon Systems
Duke University
Dynacare Laboratories
Enterix
EntroGen
Esoterix
European Diagnostic Manufacturers Association (EDMA)
European Medicines Evaluation Agency (EMEA)
Focus Diagnostics
Food and Drug Administration (FDA)
Genetics & Public Policy Center
HemoCue
Hologic
Home Access Health
Laboratory Corporation of America
Litholink Corporation
Modern Health Systems
Monogram Bioscience
Myriad Genetics
National Genetics Institute
National Health Service (UK NHS)
Navigenics
OraSure Technologies
Oxford Immunotec
ParagonDx
Pathway Genomics
Pfizer
Prometheus
Qiagen
Quest Diagnostics
Radient Pharmaceuticals
Roche
Siemens
US LABS
Vermillion Diagnostics
ViroMed Laboratories
Walgreens
Warner-Chilcott
World Health Organization (WHO)


Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact

Order Information
Please verify that the product information is correct and select the format(s) you require.

In Vitro Diagnostics and Theranostics: World Market Analysis 2010-2025

Product Formats
Please select the product formats and the quantity you require.

1 User License--USD 2 496.90 Quantity: _____

Department License--USD 4 995.25 Quantity: _____

Site License--USD 8 325.90 Quantity: _____

Corporate License--USD 11 656.55 Quantity: _____

Contact Information
Please enter all the information below in BLOCK CAPITALS

Title: Mr Mrs Dr Miss Ms Prof

First Name: _____________________________ Last Name: __________________________________

Email Address: __________________________________________________________________________

Job Title: __________________________________________________________________________

Organization: __________________________________________________________________________

Address: __________________________________________________________________________

City: __________________________________________________________________________

Postal / Zip Code: __________________________________________________________________________

Country: __________________________________________________________________________

Phone Number: __________________________________________________________________________

Fax Number: __________________________________________________________________________


Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card Card Number: ______________________________________________

Expiry Date __________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189

Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms

Please fax this form to:

Europe, Middle East and Africa : + 33 4 37 37 15 56

Asia, Oceania and America : + 1 (805) 617 17 93


In Vitro Diagnostics and Theranostics: World Market Analysis 2010-2025

Recommended

Recommended

More Related Content

Viewers also liked

Viewers also liked (16)

More from ReportLinker.com

More from ReportLinker.com (20)

In Vitro Diagnostics and Theranostics: World Market Analysis 2010-2025